Circulating microRNAs as novel minimally invasive biomarkers for breast cancer
The development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular biology. Mi(cro)RNAs have many characteristics of an ideal biomarker most notably their inherent stability and resilience. Recent blood-based miRN...
Gespeichert in:
| Veröffentlicht in: | Annals of surgery Jg. 251; H. 3; S. 499 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.03.2010
|
| Schlagworte: | |
| ISSN: | 1528-1140, 1528-1140 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular biology. Mi(cro)RNAs have many characteristics of an ideal biomarker most notably their inherent stability and resilience. Recent blood-based miRNA profiling studies, reporting their presence in serum and plasma, have generated the concept that circulating miRNAs hold much potential as novel noninvasive biomarkers for cancer and other disease processes. The objective of this study was to investigate the potential of circulating microRNAs as novel breast cancer biomarkers.
Using a novel approach to extract miRNAs from the circulation followed by real-time quantitative polymerase chain reaction analysis, levels of a panel of 7 candidate miRNAs were quantified in tissue and blood specimens of 148 patients with breast cancer and 44 age-matched and disease free control individuals.
We report that cancer-specific miRNAs were detected and significantly altered in the circulation of breast cancer patients, and that increased systemic miR-195 levels in breast cancer patients were reflected in breast tumors. Furthermore, we identified that circulating levels of miR-195 and let-7a decreased in cancer patients postoperatively, to levels comparable with control subjects, following curative tumor resection. Finally, we found that specific circulating miRNAs correlated with certain clinicopathological variables, namely nodal status and estrogen receptor status.
These findings suggest that systemic miRNAs have potential use as novel breast cancer biomarkers and may prove useful in clinical management during the perioperative period. |
|---|---|
| AbstractList | The development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular biology. Mi(cro)RNAs have many characteristics of an ideal biomarker most notably their inherent stability and resilience. Recent blood-based miRNA profiling studies, reporting their presence in serum and plasma, have generated the concept that circulating miRNAs hold much potential as novel noninvasive biomarkers for cancer and other disease processes. The objective of this study was to investigate the potential of circulating microRNAs as novel breast cancer biomarkers.OBJECTIVEThe development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular biology. Mi(cro)RNAs have many characteristics of an ideal biomarker most notably their inherent stability and resilience. Recent blood-based miRNA profiling studies, reporting their presence in serum and plasma, have generated the concept that circulating miRNAs hold much potential as novel noninvasive biomarkers for cancer and other disease processes. The objective of this study was to investigate the potential of circulating microRNAs as novel breast cancer biomarkers.Using a novel approach to extract miRNAs from the circulation followed by real-time quantitative polymerase chain reaction analysis, levels of a panel of 7 candidate miRNAs were quantified in tissue and blood specimens of 148 patients with breast cancer and 44 age-matched and disease free control individuals.METHODSUsing a novel approach to extract miRNAs from the circulation followed by real-time quantitative polymerase chain reaction analysis, levels of a panel of 7 candidate miRNAs were quantified in tissue and blood specimens of 148 patients with breast cancer and 44 age-matched and disease free control individuals.We report that cancer-specific miRNAs were detected and significantly altered in the circulation of breast cancer patients, and that increased systemic miR-195 levels in breast cancer patients were reflected in breast tumors. Furthermore, we identified that circulating levels of miR-195 and let-7a decreased in cancer patients postoperatively, to levels comparable with control subjects, following curative tumor resection. Finally, we found that specific circulating miRNAs correlated with certain clinicopathological variables, namely nodal status and estrogen receptor status.RESULTSWe report that cancer-specific miRNAs were detected and significantly altered in the circulation of breast cancer patients, and that increased systemic miR-195 levels in breast cancer patients were reflected in breast tumors. Furthermore, we identified that circulating levels of miR-195 and let-7a decreased in cancer patients postoperatively, to levels comparable with control subjects, following curative tumor resection. Finally, we found that specific circulating miRNAs correlated with certain clinicopathological variables, namely nodal status and estrogen receptor status.These findings suggest that systemic miRNAs have potential use as novel breast cancer biomarkers and may prove useful in clinical management during the perioperative period.CONCLUSIONThese findings suggest that systemic miRNAs have potential use as novel breast cancer biomarkers and may prove useful in clinical management during the perioperative period. The development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular biology. Mi(cro)RNAs have many characteristics of an ideal biomarker most notably their inherent stability and resilience. Recent blood-based miRNA profiling studies, reporting their presence in serum and plasma, have generated the concept that circulating miRNAs hold much potential as novel noninvasive biomarkers for cancer and other disease processes. The objective of this study was to investigate the potential of circulating microRNAs as novel breast cancer biomarkers. Using a novel approach to extract miRNAs from the circulation followed by real-time quantitative polymerase chain reaction analysis, levels of a panel of 7 candidate miRNAs were quantified in tissue and blood specimens of 148 patients with breast cancer and 44 age-matched and disease free control individuals. We report that cancer-specific miRNAs were detected and significantly altered in the circulation of breast cancer patients, and that increased systemic miR-195 levels in breast cancer patients were reflected in breast tumors. Furthermore, we identified that circulating levels of miR-195 and let-7a decreased in cancer patients postoperatively, to levels comparable with control subjects, following curative tumor resection. Finally, we found that specific circulating miRNAs correlated with certain clinicopathological variables, namely nodal status and estrogen receptor status. These findings suggest that systemic miRNAs have potential use as novel breast cancer biomarkers and may prove useful in clinical management during the perioperative period. |
| Author | Kerin, Michael J Lowery, Aoife J Sweeney, Karl J Newell, John Heneghan, Helen M Miller, Nicola |
| Author_xml | – sequence: 1 givenname: Helen M surname: Heneghan fullname: Heneghan, Helen M organization: Department of Surgery, National University of Ireland, Galway, Ireland – sequence: 2 givenname: Nicola surname: Miller fullname: Miller, Nicola – sequence: 3 givenname: Aoife J surname: Lowery fullname: Lowery, Aoife J – sequence: 4 givenname: Karl J surname: Sweeney fullname: Sweeney, Karl J – sequence: 5 givenname: John surname: Newell fullname: Newell, John – sequence: 6 givenname: Michael J surname: Kerin fullname: Kerin, Michael J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20134314$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUNtKAzEUDFKxF_0Dkbz5tJrbNpvHUrxBqeDleUnOZiWaTWqyW-jfu2AFn2Y4zAxzZo4mIQaL0CUlN5Qoefu6Wd0QQyi3nFYUQHHVnqAZLVlVUCrI5B-fonnOn4RQURF5hqZstAlOxQxt1y7B4HXvwgfuHKT4sl1lrDMOcW_9eAqu094fsAt7nd3eYuNip9OXTRm3MWGTrM49Bh3ApnN02mqf7cURF-j9_u5t_Vhsnh-e1qtNAYKwvhBGamVAVq1QjIApm1JVBjQVbSuAEEaE5MYaaSoJFBq2LKnkDMb6rOGGsQW6_s3dpfg92NzXnctgvdfBxiHXkvOlZGr0LNDVUTmYzjb1Lo3_pEP9NwH7AaY2YXY |
| CitedBy_id | crossref_primary_10_3389_fgene_2019_00169 crossref_primary_10_1002_ijc_29985 crossref_primary_10_1007_s00277_015_2414_z crossref_primary_10_1155_2014_486413 crossref_primary_10_1007_s13277_014_3008_4 crossref_primary_10_1016_j_joca_2015_10_018 crossref_primary_10_1074_jbc_M111_224212 crossref_primary_10_1371_journal_pone_0064795 crossref_primary_10_1007_s40291_016_0233_0 crossref_primary_10_1371_journal_pone_0101950 crossref_primary_10_1186_s12885_019_5884_x crossref_primary_10_1371_journal_pone_0090605 crossref_primary_10_1159_000489321 crossref_primary_10_1016_j_bbcan_2012_03_001 crossref_primary_10_1038_bjc_2011_198 crossref_primary_10_3760_cma_j_issn_0366_6999_20123142 crossref_primary_10_1186_s12885_017_3751_1 crossref_primary_10_1007_s13277_016_4907_3 crossref_primary_10_3390_ijms241612694 crossref_primary_10_1016_j_coph_2010_05_010 crossref_primary_10_3389_fgene_2018_00616 crossref_primary_10_3390_biom14121580 crossref_primary_10_1016_j_rvsc_2019_12_001 crossref_primary_10_1080_10255842_2023_2235045 crossref_primary_10_1016_j_biopha_2017_01_133 crossref_primary_10_1007_s40291_018_0316_1 crossref_primary_10_1007_s40291_015_0143_6 crossref_primary_10_1186_bcr3127 crossref_primary_10_1586_era_11_197 crossref_primary_10_1111_jcmm_12625 crossref_primary_10_3390_cells9020276 crossref_primary_10_6061_clinics_2021_e2142 crossref_primary_10_1016_j_bbrc_2014_08_002 crossref_primary_10_1371_journal_pone_0029770 crossref_primary_10_1016_j_critrevonc_2010_11_004 crossref_primary_10_2217_pgs_12_15 crossref_primary_10_1093_abbs_gmr080 crossref_primary_10_1016_j_canep_2012_04_001 crossref_primary_10_1016_j_pharmthera_2019_107437 crossref_primary_10_1186_s13058_020_01295_6 crossref_primary_10_1002_ijc_28563 crossref_primary_10_1016_j_critrevonc_2022_103897 crossref_primary_10_1371_journal_pone_0091927 crossref_primary_10_1053_j_seminoncol_2011_08_005 crossref_primary_10_1007_s12253_019_00627_y crossref_primary_10_1053_j_seminoncol_2011_08_007 crossref_primary_10_1016_j_jab_2016_09_002 crossref_primary_10_3390_cancers14092109 crossref_primary_10_1007_s12013_014_0459_6 crossref_primary_10_3892_ol_2012_841 crossref_primary_10_1038_s41598_017_16978_y crossref_primary_10_1016_j_talanta_2015_09_010 crossref_primary_10_1016_j_mce_2011_09_041 crossref_primary_10_1016_j_ymthe_2019_07_006 crossref_primary_10_1371_journal_pone_0158946 crossref_primary_10_1007_s10911_012_9245_5 crossref_primary_10_1016_j_bios_2012_04_032 crossref_primary_10_1038_s41598_020_74685_7 crossref_primary_10_1111_odi_12073 crossref_primary_10_1371_journal_pone_0028423 crossref_primary_10_1371_journal_pone_0078649 crossref_primary_10_1016_j_addr_2014_09_001 crossref_primary_10_1007_s00432_023_05215_x crossref_primary_10_1016_j_exphem_2016_03_005 crossref_primary_10_1038_s41467_018_03537_w crossref_primary_10_1016_j_omtn_2020_07_026 crossref_primary_10_1007_s00404_021_06287_1 crossref_primary_10_2217_bmm_14_102 crossref_primary_10_1007_s11033_019_05235_2 crossref_primary_10_1016_j_clinbiochem_2013_01_027 crossref_primary_10_1016_j_trsl_2020_04_002 crossref_primary_10_1371_journal_pone_0152032 crossref_primary_10_3390_jcm4071369 crossref_primary_10_3892_ol_2012_863 crossref_primary_10_1002_jcb_27984 crossref_primary_10_1007_s12291_022_01053_9 crossref_primary_10_3389_fgene_2023_1052731 crossref_primary_10_3390_gidisord4030018 crossref_primary_10_1007_s10404_021_02437_8 crossref_primary_10_1002_mc_20712 crossref_primary_10_1007_s10549_010_0980_2 crossref_primary_10_1038_bjc_2015_340 crossref_primary_10_12677_MD_2015_53010 crossref_primary_10_1177_1010428317695018 crossref_primary_10_3892_mmr_2015_4722 crossref_primary_10_1016_j_canlet_2015_07_045 crossref_primary_10_1038_bjc_2015_463 crossref_primary_10_1016_j_gene_2018_11_055 crossref_primary_10_1016_j_aca_2017_03_032 crossref_primary_10_1371_journal_pone_0056634 crossref_primary_10_1002_tox_22099 crossref_primary_10_3892_ol_2018_8645 crossref_primary_10_2217_fon_2018_0061 crossref_primary_10_1093_humrep_des413 crossref_primary_10_1007_s12020_016_0878_9 crossref_primary_10_1109_TCBB_2024_3421924 crossref_primary_10_1002_pros_23748 crossref_primary_10_1002_wrna_1149 crossref_primary_10_1007_s13277_014_1846_8 crossref_primary_10_1016_j_bbrc_2014_10_064 crossref_primary_10_3892_mmr_2017_6547 crossref_primary_10_1016_j_canlet_2012_01_020 crossref_primary_10_3892_or_2014_2983 crossref_primary_10_1038_bjc_2015_111 crossref_primary_10_3109_1354750X_2012_686061 crossref_primary_10_1007_s00404_015_3702_5 crossref_primary_10_1007_s13277_014_2533_5 crossref_primary_10_3390_proteomes5040025 crossref_primary_10_1016_j_gde_2013_01_004 crossref_primary_10_3390_ijms14034934 crossref_primary_10_1155_2014_592868 crossref_primary_10_1007_s12033_011_9414_6 crossref_primary_10_5812_ijcm_88829 crossref_primary_10_1016_j_canlet_2012_11_001 crossref_primary_10_1186_bcr3428 crossref_primary_10_1371_journal_pone_0057841 crossref_primary_10_1373_clinchem_2013_216044 crossref_primary_10_1111_cpr_12262 crossref_primary_10_1186_1471_2407_11_500 crossref_primary_10_1186_1471_2407_14_200 crossref_primary_10_1371_journal_pone_0024145 crossref_primary_10_4137_BMI_S11153 crossref_primary_10_3389_fgene_2016_00175 crossref_primary_10_1016_j_critrevonc_2015_07_002 crossref_primary_10_1177_147323001204000304 crossref_primary_10_3390_diagnostics12081973 crossref_primary_10_1007_s00277_014_2111_3 crossref_primary_10_3892_mco_2015_567 crossref_primary_10_1002_jbt_20396 crossref_primary_10_1016_j_jad_2017_06_058 crossref_primary_10_1007_s12032_012_0303_z crossref_primary_10_3892_mmr_2018_8645 crossref_primary_10_1016_j_jmhi_2013_03_003 crossref_primary_10_3892_ol_2018_9175 crossref_primary_10_1371_journal_pone_0013247 crossref_primary_10_1158_1541_7786_MCR_14_0543 crossref_primary_10_3390_biomedicines12030691 crossref_primary_10_1016_j_molonc_2016_10_004 crossref_primary_10_1371_journal_pone_0053141 crossref_primary_10_1016_j_bioorg_2020_104605 crossref_primary_10_1016_j_juro_2014_07_010 crossref_primary_10_1016_j_biopha_2016_01_026 crossref_primary_10_1016_j_yjmcc_2013_05_011 crossref_primary_10_1158_1078_0432_CCR_12_3401 crossref_primary_10_1016_j_molonc_2014_02_009 crossref_primary_10_3390_mi10100698 crossref_primary_10_1016_j_mce_2017_02_004 crossref_primary_10_1371_journal_pone_0151345 crossref_primary_10_3390_molecules19056282 crossref_primary_10_1186_s12885_015_1190_4 crossref_primary_10_3390_cancers13153838 crossref_primary_10_1007_s40820_015_0079_8 crossref_primary_10_1634_theoncologist_2010_0103 crossref_primary_10_1111_cas_14764 crossref_primary_10_1002_cam4_973 crossref_primary_10_3390_biomedicines11020563 crossref_primary_10_1016_j_ijsu_2012_08_006 crossref_primary_10_1373_clinchem_2010_150730 crossref_primary_10_1186_s12885_018_4020_7 crossref_primary_10_3390_molecules19021912 crossref_primary_10_1371_journal_pone_0087032 crossref_primary_10_3109_1354750X_2014_955059 crossref_primary_10_6061_clinics_2018_e184 crossref_primary_10_3748_wjg_v21_i2_511 crossref_primary_10_1016_j_jceh_2013_09_001 crossref_primary_10_1007_s13277_014_2587_4 crossref_primary_10_1371_journal_pone_0083718 crossref_primary_10_1371_journal_pone_0137389 crossref_primary_10_5812_pmco_117729 crossref_primary_10_1002_jcb_28782 crossref_primary_10_1016_j_urolonc_2010_12_017 crossref_primary_10_2217_bmm_13_43 crossref_primary_10_1007_s13277_015_4292_3 crossref_primary_10_1200_JCO_2010_29_8901 crossref_primary_10_1186_1471_2407_14_44 crossref_primary_10_1111_j_1464_410X_2012_11244_x crossref_primary_10_1371_journal_pone_0025787 crossref_primary_10_3390_ijms20122878 crossref_primary_10_1186_s12885_015_1238_5 crossref_primary_10_3390_diagnostics14192211 crossref_primary_10_1002_cam4_1026 crossref_primary_10_3390_medicina56070340 crossref_primary_10_1371_journal_pone_0253009 crossref_primary_10_1002_cncr_26565 crossref_primary_10_1007_s00292_013_1878_7 crossref_primary_10_1016_j_ctrv_2013_11_002 crossref_primary_10_1017_S1460396920000746 crossref_primary_10_1002_jcb_27347 crossref_primary_10_3892_ol_2018_9012 crossref_primary_10_1016_j_breast_2017_06_024 crossref_primary_10_1016_j_ejso_2011_05_005 crossref_primary_10_1016_j_trsl_2015_07_007 crossref_primary_10_25122_jml_2024_0322 crossref_primary_10_1007_s10555_020_09905_7 crossref_primary_10_1016_j_ab_2019_113349 crossref_primary_10_3892_ol_2016_4710 crossref_primary_10_1016_j_exger_2014_12_014 crossref_primary_10_1186_s12967_019_1923_2 crossref_primary_10_1016_j_bbrc_2010_08_046 crossref_primary_10_1111_cas_15309 crossref_primary_10_3390_cancers14092317 crossref_primary_10_1007_s10549_018_4850_7 crossref_primary_10_1016_j_bios_2020_112815 crossref_primary_10_1007_s00216_017_0298_6 crossref_primary_10_2217_fon_2018_0334 crossref_primary_10_3390_biomedicines11113007 crossref_primary_10_1007_s12032_012_0337_2 crossref_primary_10_1016_j_gene_2021_145844 crossref_primary_10_1111_j_1749_6632_2010_05803_x crossref_primary_10_3892_ijo_2018_4516 crossref_primary_10_1371_journal_pone_0081408 crossref_primary_10_1016_j_bios_2022_114236 crossref_primary_10_3390_ijms232315382 crossref_primary_10_1007_s13167_017_0083_9 crossref_primary_10_1016_j_tranon_2020_100995 crossref_primary_10_1093_nar_gkv724 crossref_primary_10_1371_journal_pone_0023584 crossref_primary_10_1007_s10238_014_0332_3 crossref_primary_10_2217_fon_12_192 crossref_primary_10_1016_j_prp_2023_154825 crossref_primary_10_1038_bjc_2013_8 crossref_primary_10_1586_erm_11_11 crossref_primary_10_1007_s40291_015_0161_4 crossref_primary_10_3233_CBM_180032 crossref_primary_10_1016_j_prp_2023_154784 crossref_primary_10_1002_ijc_30179 crossref_primary_10_1007_s10555_015_9551_7 crossref_primary_10_1016_j_phrs_2015_04_015 crossref_primary_10_3390_ijms24098270 crossref_primary_10_1016_j_lfs_2015_10_003 crossref_primary_10_2217_pme_2020_0010 crossref_primary_10_1007_s12029_022_00877_1 crossref_primary_10_3390_cancers2021066 crossref_primary_10_3390_ijms20184353 crossref_primary_10_1073_pnas_1019055108 crossref_primary_10_1007_s10911_013_9274_8 crossref_primary_10_1016_j_ajpath_2017_11_003 crossref_primary_10_1097_XCS_0000000000000465 crossref_primary_10_1016_j_proeng_2015_08_593 crossref_primary_10_1007_s10555_010_9265_9 crossref_primary_10_3390_ijms161023382 crossref_primary_10_1089_dna_2012_1654 crossref_primary_10_3892_ijmm_2012_894 crossref_primary_10_3390_cancers15010128 crossref_primary_10_1016_j_bios_2016_08_028 crossref_primary_10_1007_s10549_023_07033_8 crossref_primary_10_1016_j_microc_2025_113919 crossref_primary_10_1371_journal_pone_0013515 crossref_primary_10_21926_obm_genet_2401215 crossref_primary_10_3892_or_2013_2443 crossref_primary_10_1007_s00216_022_04182_5 crossref_primary_10_2217_bmm_13_12 crossref_primary_10_1097_SLA_0000000000005613 crossref_primary_10_1186_1746_6148_9_12 crossref_primary_10_3390_cancers12071820 crossref_primary_10_1038_leu_2012_179 crossref_primary_10_3109_01443615_2014_920782 crossref_primary_10_1016_j_urology_2011_01_020 crossref_primary_10_1111_cas_13725 crossref_primary_10_1371_journal_pgen_1008592 crossref_primary_10_1002_adtp_202300408 crossref_primary_10_1038_s41388_018_0420_z crossref_primary_10_1373_clinchem_2010_147850 crossref_primary_10_1155_2022_9321763 crossref_primary_10_2217_bmm_10_73 crossref_primary_10_1186_s12967_016_1025_3 crossref_primary_10_1007_s00411_016_0661_6 crossref_primary_10_3892_mco_2013_61 crossref_primary_10_1186_bcr2943 crossref_primary_10_3892_or_2023_8661 crossref_primary_10_1134_S1022795419080167 crossref_primary_10_1371_journal_pone_0159369 crossref_primary_10_1038_bjc_2012_546 crossref_primary_10_3390_ijms150610508 crossref_primary_10_1371_journal_pone_0013735 crossref_primary_10_1177_0300060513497560 crossref_primary_10_1186_bcr2812 crossref_primary_10_1016_j_biopha_2016_03_007 crossref_primary_10_1111_j_1743_7563_2012_01548_x crossref_primary_10_1186_1756_8722_7_6 crossref_primary_10_3390_ijms13010840 crossref_primary_10_1016_j_gene_2019_144104 crossref_primary_10_1016_j_intimp_2020_106970 crossref_primary_10_1007_s00018_020_03703_8 crossref_primary_10_1002_ejhf_223 crossref_primary_10_3390_life11101055 crossref_primary_10_1158_0008_5472_CAN_10_1001 crossref_primary_10_1097_MPA_0000000000000383 crossref_primary_10_1186_s13046_018_0966_1 crossref_primary_10_1016_j_bbcan_2014_10_005 crossref_primary_10_3390_genes15050574 crossref_primary_10_1042_BSR20181223 crossref_primary_10_1155_2019_8393769 crossref_primary_10_1517_14712598_2012_681373 crossref_primary_10_3389_fonc_2025_1529907 crossref_primary_10_1038_nrclinonc_2011_76 crossref_primary_10_1007_s13277_013_0753_8 crossref_primary_10_1007_s10549_018_4757_3 crossref_primary_10_2165_11537800_000000000_00000 crossref_primary_10_3389_fcvm_2025_1529451 crossref_primary_10_3390_cells11061008 crossref_primary_10_1155_2014_642916 crossref_primary_10_1227_NEU_0000000000000369 crossref_primary_10_1517_14728222_2011_650632 crossref_primary_10_1080_15384101_2017_1387699 crossref_primary_10_3389_fcell_2014_00061 crossref_primary_10_3390_diagnostics12040789 crossref_primary_10_3390_ijms24043497 crossref_primary_10_1053_j_gastro_2012_04_007 crossref_primary_10_1007_s00384_011_1279_4 crossref_primary_10_1186_1479_5876_10_42 crossref_primary_10_4161_15592294_2014_989088 crossref_primary_10_1002_jso_23344 crossref_primary_10_1007_s00432_012_1315_y crossref_primary_10_1007_s12032_016_0749_5 crossref_primary_10_1016_j_semcancer_2018_01_007 crossref_primary_10_4103_jrms_JRMS_967_16 crossref_primary_10_1136_bmjopen_2012_000825 crossref_primary_10_1080_14686996_2016_1189798 crossref_primary_10_1016_j_molmed_2011_01_006 crossref_primary_10_3390_ijms140510307 crossref_primary_10_1016_j_jss_2015_02_027 crossref_primary_10_3390_ncrna2040013 crossref_primary_10_1016_j_bios_2022_114404 crossref_primary_10_1097_MS9_0000000000002075 crossref_primary_10_1016_j_lfs_2015_10_029 crossref_primary_10_2217_fon_14_294 crossref_primary_10_1016_j_molonc_2014_03_002 crossref_primary_10_3390_cancers11081181 crossref_primary_10_1093_carcin_bgs030 crossref_primary_10_1097_CCO_0b013e32833de186 crossref_primary_10_1158_1541_7786_MCR_12_0649 crossref_primary_10_3390_s24175747 crossref_primary_10_1186_s12885_019_5636_y crossref_primary_10_3892_ijo_2013_2169 crossref_primary_10_1016_S1470_2045_12_70073_6 crossref_primary_10_1007_s10555_012_9414_4 crossref_primary_10_1097_MD_0000000000026103 crossref_primary_10_1007_s11042_021_11653_x crossref_primary_10_3390_ijerph121113981 crossref_primary_10_1016_j_ab_2012_06_021 crossref_primary_10_1038_bjc_2014_451 crossref_primary_10_1002_jso_23245 crossref_primary_10_1371_journal_pone_0124245 crossref_primary_10_1097_TP_0000000000000625 crossref_primary_10_1515_cclm_2012_0360 crossref_primary_10_1016_j_ijnurstu_2019_103419 crossref_primary_10_1016_j_fct_2016_03_027 crossref_primary_10_1038_bonekey_2015_38 crossref_primary_10_1007_s00223_017_0296_x crossref_primary_10_1111_exd_14124 crossref_primary_10_1371_journal_pone_0083113 crossref_primary_10_1111_brv_12176 crossref_primary_10_1007_s13402_012_0089_1 crossref_primary_10_3390_ijms26073449 crossref_primary_10_3892_ol_2016_5214 crossref_primary_10_1089_dna_2024_0170 crossref_primary_10_1016_j_jopr_2013_02_033 crossref_primary_10_1371_journal_pgen_1007790 crossref_primary_10_1586_14737159_2014_901153 crossref_primary_10_3390_cancers14030729 crossref_primary_10_1200_JCO_2010_29_9487 crossref_primary_10_1371_journal_pone_0020687 crossref_primary_10_1158_1078_0432_CCR_10_1800 crossref_primary_10_3390_cancers11070901 crossref_primary_10_1186_bcr3649 crossref_primary_10_5306_wjco_v5_i2_71 crossref_primary_10_1186_bcr2798 crossref_primary_10_3892_ol_2016_5462 crossref_primary_10_1158_1940_6207_CAPR_11_0370 crossref_primary_10_1016_j_humpath_2016_11_001 crossref_primary_10_1016_j_lfs_2017_08_017 crossref_primary_10_1186_s12885_024_12500_6 crossref_primary_10_1371_journal_pone_0054932 crossref_primary_10_1371_journal_pone_0050459 crossref_primary_10_3390_biomedicines12122659 crossref_primary_10_2217_crc_13_46 crossref_primary_10_1002_cncr_28254 crossref_primary_10_1159_000351767 crossref_primary_10_1038_bjc_2011_453 crossref_primary_10_1007_s00432_012_1244_9 crossref_primary_10_1016_j_mrfmmm_2011_03_004 crossref_primary_10_3390_ijms22147653 crossref_primary_10_1002_jcp_26379 crossref_primary_10_32604_or_2022_027277 crossref_primary_10_1016_j_ultrasmedbio_2012_12_015 crossref_primary_10_1038_s41598_020_59682_0 crossref_primary_10_1007_s12253_019_00622_3 crossref_primary_10_3389_fonc_2021_722828 crossref_primary_10_3892_ol_2013_1593 crossref_primary_10_1002_ijc_27997 crossref_primary_10_1053_j_seminoncol_2012_05_013 crossref_primary_10_1002_jcb_28173 crossref_primary_10_1111_j_1349_7006_2010_01650_x crossref_primary_10_3389_fmolb_2022_1030749 crossref_primary_10_1155_2014_435476 crossref_primary_10_1586_era_11_40 crossref_primary_10_1002_ijc_27642 crossref_primary_10_3892_ijmm_2014_2016 crossref_primary_10_1245_s10434_015_4586_0 crossref_primary_10_1186_1471_2407_13_280 crossref_primary_10_1186_1472_6750_11_70 crossref_primary_10_1093_bib_bbac021 crossref_primary_10_1002_jso_23174 crossref_primary_10_3390_ph11020035 crossref_primary_10_1242_dmm_010835 crossref_primary_10_1016_j_biopha_2016_04_011 crossref_primary_10_1016_j_jhep_2011_04_026 crossref_primary_10_1177_1010428317695525 crossref_primary_10_1186_bcr2766 crossref_primary_10_1371_journal_pone_0022839 crossref_primary_10_3390_ijms12032055 crossref_primary_10_1002_biof_1676 crossref_primary_10_1016_j_jrras_2022_08_001 crossref_primary_10_1007_s00432_013_1469_2 crossref_primary_10_1016_j_lfs_2020_117417 crossref_primary_10_1016_j_critrevonc_2015_04_002 crossref_primary_10_1186_s10020_025_01137_1 crossref_primary_10_1016_j_trsl_2014_01_009 crossref_primary_10_1186_s12885_017_3776_5 crossref_primary_10_1002_ijc_28757 crossref_primary_10_1007_s13277_014_2525_5 crossref_primary_10_1016_j_prp_2022_154081 crossref_primary_10_1158_1078_0432_CCR_14_2011 crossref_primary_10_3892_br_2014_343 crossref_primary_10_1186_s12967_023_04075_w crossref_primary_10_1038_srep16103 crossref_primary_10_1186_s12920_017_0260_7 crossref_primary_10_1038_bjc_2013_148 crossref_primary_10_1007_s13148_011_0040_8 crossref_primary_10_1016_j_bbmt_2019_08_004 crossref_primary_10_3390_ijms19041019 crossref_primary_10_1002_ijc_31931 crossref_primary_10_1016_j_ccr_2014_03_007 crossref_primary_10_3390_jcm8101661 crossref_primary_10_3390_biom10010150 crossref_primary_10_1089_nat_2012_0375 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/SLA.0b013e3181cc939f |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1528-1140 |
| ExternalDocumentID | 20134314 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 1J1 23M 2WC 354 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAEJM AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPPZ ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACRZS ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHJKT AHOMT AHQNM AHQVU AHRYX AHVBC AI. AIJEX AINUH AJCLO AJIOK AJJEV AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AZFZN BAWUL BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DUNZO E.X E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FEDTE FL- FW0 GNXGY GQDEL H0~ HLJTE HVGLF HZ~ IH2 IKREB IKYAY IN~ IPNFZ J5H JF7 JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 N4W N9A NPM N~7 N~B N~M O9- OAG OAH OBH OCB OCUKA ODA ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ RPM RXW S4R S4S T8P TAF TEORI TR2 TSPGW UQX V2I VH1 VVN W3M WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC ZFV ZGI ZXP ZY1 ZZMQN ~H1 7X8 ABPXF ADKSD |
| ID | FETCH-LOGICAL-c402t-4b7a9bc78f4920cb5d598bca14ff4c0020473beb7b87c1cd2651732c4802d3b22 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 582 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000275060800019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-1140 |
| IngestDate | Wed Oct 01 14:49:20 EDT 2025 Thu Apr 03 07:01:52 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c402t-4b7a9bc78f4920cb5d598bca14ff4c0020473beb7b87c1cd2651732c4802d3b22 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 20134314 |
| PQID | 733672973 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_733672973 pubmed_primary_20134314 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-03-01 |
| PublicationDateYYYYMMDD | 2010-03-01 |
| PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Annals of surgery |
| PublicationTitleAlternate | Ann Surg |
| PublicationYear | 2010 |
| SSID | ssj0014807 |
| Score | 2.535549 |
| Snippet | The development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 499 |
| SubjectTerms | Adult Aged Aged, 80 and over Biomarkers - blood Breast Neoplasms - blood Female Humans MicroRNAs - blood Middle Aged Prospective Studies |
| Title | Circulating microRNAs as novel minimally invasive biomarkers for breast cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/20134314 https://www.proquest.com/docview/733672973 |
| Volume | 251 |
| WOSCitedRecordID | wos000275060800019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAMrDwEK_ykgfWqI3txPaEqoqKAaKKh9Qtsi8JqtQmJSmV-Pf4kpROiIElm6X4dGd_5_vuPkJusbhjfT_xLEahEAAupELrhVZwBRkkfQa12ISMIjWZ6HHLzalaWuX6TKwP6qQAfCPv4dg-iUJLd4sPD0WjsLjaKmhskw53SAadWk42RYS2W9rdUC5RconEunNOy97L42DzBOgDaK6z3zFmfdeMDv75l4dkvwWZdNB4xRHZSvNjEg2nJdRiXfk7nSMP7zkaVNRUNC9W6YzikJG5mc2-6DRfGWS1U-zNR_pOWVGHbalFAvuSAjpKeULeRvevwwevVVPwwOWIS09YabQFqTKhWR9skARaWTC-yDIBdZOs5Da10ioJPiQsDHzJGTgrsoRbxk7JTl7k6Tmhbn_GcmDapbJChb7SwgTCbV0ro7QRXULX1omdt2IJwuRp8VnFP_bpkrPGwvGimaoROyTCHZoRF38vviR7TREfqWBXpJO5SE2vyS6sltOqvKm9wH2j8dM3CLm70g |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+microRNAs+as+novel+minimally+invasive+biomarkers+for+breast+cancer&rft.jtitle=Annals+of+surgery&rft.au=Heneghan%2C+Helen+M&rft.au=Miller%2C+Nicola&rft.au=Lowery%2C+Aoife+J&rft.au=Sweeney%2C+Karl+J&rft.date=2010-03-01&rft.eissn=1528-1140&rft.volume=251&rft.issue=3&rft.spage=499&rft_id=info:doi/10.1097%2FSLA.0b013e3181cc939f&rft_id=info%3Apmid%2F20134314&rft_id=info%3Apmid%2F20134314&rft.externalDocID=20134314 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-1140&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-1140&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-1140&client=summon |